Inferring Numbers of Wild Poliovirus Excretors Using Quantitative Environmental Surveillance

Inferring Numbers of Wild Poliovirus Excretors Using Quantitative Environmental Surveillance

Response to and monitoring of viral outbreaks can be efficiently focused when rapid, quantitative, kinetic information provides the location and the number of infected individuals. Environmental surveillance traditionally provides information on location of populations with contagious, infected indi...

Full description

Bibliographic Details
Main Authors:	Yuri Perepliotchikov, Tomer Ziv-Baran, Musa Hindiyeh, Yossi Manor, Danit Sofer, Jacob Moran-Gilad, Laura Stephens, Ella Mendelson, Merav Weil, Ravit Bassal, Emilia Anis, Shepherd Roee Singer, Ehud Kaliner, Gillian Cooper, Manasi Majumdar, Michal Markovich, Daniela Ram, Itamar Grotto, Ronni Gamzu, Javier Martin, Lester M. Shulman
Format:	Article
Language:	English
Published:	MDPI AG 2021-08-01
Series:	Vaccines
Subjects:	poliovirus outbreaks quantitative environmental surveillance vaccination oral poliovirus vaccine inactivated poliovirus vaccine
Online Access:	https://www.mdpi.com/2076-393X/9/8/870

Similar Items

The Fight against Poliovirus Is Not Over
by: Chaldam Jespère Mbani, et al.
Published: (2023-05-01)

The Molecular Evolution of Type 2 Vaccine-Derived Polioviruses in Individuals with Primary Immunodeficiency Diseases
by: Kouichi Kitamura, et al.
Published: (2021-07-01)

A phase 2 study of a combined diphtheria-tetanus-acellular pertussis vaccine with a Sabin-derived inactivated poliovirus vaccine in children
by: Takashi Nakano, et al.
Published: (2018-12-01)

Vaccine-Derived Polioviruses and Children with Primary Immunodeficiency, Iran, 1995–2014
by: Mohammadreza Shaghaghi, et al.
Published: (2016-10-01)

Global epidemiology of vaccine-derived poliovirus 2016–2021: A descriptive analysis and retrospective case-control study
by: Yi An Lai, et al.
Published: (2022-08-01)

Immunogenicity of sequential inactivated and oral poliovirus vaccines (OPV) versus inactivated poliovirus vaccine (IPV) alone in healthy infants: A systematic review and meta-analysis
by: Guihua Tang, et al.
Published: (2018-11-01)

Prolonged Excretion of Poliovirus among Individuals with Primary Immunodeficiency Disorder: An Analysis of the World Health Organization Registry
by: Grace Macklin, et al.
Published: (2017-09-01)

Seroprevalence of poliovirus antibodies before and after polio vaccine switch in 2012 and 2017 in Beijing
by: Juan Li, et al.
Published: (2021-02-01)

Vaccine-Derived Polioviruses, Central African Republic, 2019
by: Marie-Line Joffret, et al.
Published: (2021-02-01)

Vaccine-related poliovirus shedding in trivalent polio vaccine and human immunodeficiency virus status: analysis from under five children
by: Joanne Hassan, et al.
Published: (2017-11-01)

Reemergence of Recombinant Vaccine–derived Polioviruses in Healthy Children, Madagascar
by: Richter Razafindratsimandresy, et al.
Published: (2013-06-01)

Lessons from Vaccine-Related Poliovirus in Israel, UK and USA
by: T. Jacob John, et al.
Published: (2022-11-01)

Current polio status in the world
by: Elaine S. Lima, et al.
Published: (2021-07-01)

Poliovirus Excretion in Children with Primary Immunodeficiency Disorders, India
by: Madhu Chhanda Mohanty, et al.
Published: (2017-10-01)

Impact of polio vaccines (oral polio vaccine - OPV or inactivated polio vaccine - IPV) on rotavirus vaccine-associated intussusception
by: Camila Cristina Martini Rodrigues, et al.
Published: (2022-11-01)

Immunodeficiency-associated Vaccine-Derived Poliovirus Type 3 in Infant, South Africa, 2011
by: Nicksy Gumede, et al.
Published: (2012-06-01)

Genetic characterization and molecular evolution of type 3 vaccine-derived polioviruses from an immunodeficient patient in China
by: Qin Guo, et al.
Published: (2023-09-01)

Vaccine-derived poliovirus surveillance in China during 2001–2013: the potential challenge for maintaining polio free status
by: Hai-Bo Wang, et al.
Published: (2017-12-01)

Environmental Surveillance for Polioviruses in Haïti (2017–2019): The Dynamic Process for the Establishment and Monitoring of Sampling Sites
by: Mary M. Alleman, et al.
Published: (2021-03-01)

Case of Poliomyelitis Caused by Significantly Diverged Derivative of the Poliovirus Type 3 Vaccine Sabin Strain Circulating in the Orphanage
by: Ekaterina A. Korotkova, et al.
Published: (2020-09-01)

The effect of maternal poliovirus antibodies on the immune responses of infants to poliovirus vaccines
by: Siyue Jia, et al.
Published: (2020-08-01)

Nucleobase but not Sugar Fidelity is Maintained in the Sabin I RNA-Dependent RNA Polymerase
by: Xinran Liu, et al.
Published: (2015-10-01)

Novel Oral Poliovirus Vaccine 2 Safety Evaluation during Nationwide Supplemental Immunization Activity, Uganda, 2022
by: Farrell A. Tobolowsky, et al.
Published: (2024-04-01)

Emergence of Vaccine-derived Polioviruses, Democratic Republic of Congo, 2004–2011
by: Nicksy Gumede, et al.
Published: (2013-10-01)

Why the Furor about Polio?
by: Samuel Amo-Tachie
Published: (2023-02-01)

The risk of type 2 oral polio vaccine use in post-cessation outbreak response
by: Kevin A. McCarthy, et al.
Published: (2017-10-01)

Update on Pakistan Polio Eradication Initiative
by: Maryam Riaz Tarar
Published: (2022-06-01)

Recombination between Poliovirus and Coxsackie A Viruses of Species C: A Model of Viral Genetic Plasticity and Emergence
by: Francis Delpeyroux, et al.
Published: (2011-08-01)

CaFÉ: A Sensitive, Low-Cost Filtration Method for Detecting Polioviruses and Other Enteroviruses in Residual Waters
by: Hanen Belgasmi, et al.
Published: (2022-07-01)

Vaccine-associated paralytic poliomyelitis in Russian Federation during the period of changes in vaccination schedule (2006-2013 y.y.)
by: O. E. Ivanova, et al.
Published: (2016-02-01)

Response to back-to-back outbreaks of circulating vaccine-derived poliovirus type 2 in two nomadic pastoralist settlements in Oti Region, Ghana-2019
by: Donne Kofi Ameme, et al.
Published: (2023-01-01)

Detection and characterization of polioviruses originating from urban sewage in Yaounde and Douala, Cameroon 2016–2017
by: Daniel Kamga Njile, et al.
Published: (2019-05-01)

Estimated Effect of Inactivated Poliovirus Vaccine Campaigns, Nigeria and Pakistan, January 2014–April 2016
by: George Shirreff, et al.
Published: (2017-02-01)

Poliovirus serological assay after the cVDPV1 outbreak in Papua New Guinea: a cross-sectional study from 2020 to 2021Research in context
by: William Pomat, et al.
Published: (2024-03-01)

PROBLEMS OF FINAL PHASE POLIOMYELITIS ERADICATION PROGRAMME
by: O. P. Chernyavskaya, et al.
Published: (2017-08-01)

Poliovirus trafficking toward central nervous system via human poliovirus receptor-dependent and -independent pathway.
by: Seii eOHKA, et al.
Published: (2012-04-01)

IMMUNE STATUS OF CHILDREN TWO MONTHS TO SIX YEARS OLD TO POLIOVIRUSES I, II AND III INA RURAL AREA OF TEHRAN RELATED TO HISTORY OF VACCINATION
by: N. Sabouri, et al.
Published: (1987-12-01)

STUDY OF IMMUNITY TO POLIOVIRUSES ON CERTAIN "SILENT" TERRITORIES OF RUSSIA
by: N. I. Romanenkova, et al.
Published: (2014-06-01)

Comparison of the Immunogenicity and Safety of Three Enhanced Inactivated Poliovirus Vaccines from Different Manufacturers in Healthy Korean Infants: A Prospective Multicenter Study
by: Byung Ok Kwak, et al.
Published: (2020-04-01)

Immune responses to oral poliovirus vaccine in HIV-exposed uninfected Zimbabwean infants
by: James A. Church, et al.
Published: (2017-11-01)